Who Exports Piperacillin from India — 280 Suppliers Behind a $88.2M Market
India's piperacillin export market is supplied by 280 active exporters who collectively shipped $88.2M across 2,138 shipments. AUROBINDO PHARMA LTD leads with a 31.6% market share, followed by STERISCIENCE SPECIALTIES PRIVATE LIMITED and AUROBINDO PHARMA LIMITED. The top 5 suppliers together control 73.0% of total export value, reflecting a concentrated market structure.
Top Piperacillin Exporters from India — Ranked by Export Value
AUROBINDO PHARMA LTD is the leading piperacillin exporter from India, holding a 31.6% share of the $88.2M market across 2,138 shipments from 280 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, STERISCIENCE SPECIALTIES PRIVATE LIMITED, AUROBINDO PHARMA LIMITED, ASTRAL STERITECH PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED — collectively control 73.0% of total export value, indicating a highly concentrated market. Individual shares are: AUROBINDO PHARMA LTD (31.6%), STERISCIENCE SPECIALTIES PRIVATE LIMITED (17.1%), AUROBINDO PHARMA LIMITED (12.4%), ASTRAL STERITECH PRIVATE LIMITED (6.7%), EUGIA PHARMA SPECIALITIES LIMITED (5.2%).
Top Piperacillin Exporters from India
Ranked by export value · 280 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD PIPERACILLIN & TAZOBACTAM FOR INJECTIONPIPERACILLIN & TAZOBACTAM FORPIPERACILLIN AND TAZOBACTAM FOR INJECTIO | $27.9M | 18 | 31.6% |
| 2 | STERISCIENCE SPECIALTIES PRIVATE LIMITED PIPERACILLIN & TAZOBACTAM FOR INJECTIONPIPERACILLIN AND TAZOBACTAM FOR INJECTIOPIPERACILLIN & TAZOBACTAM FOR | $15.1M | 5 | 17.1% |
| 3 | AUROBINDO PHARMA LIMITED PIPERACILLIN & TAZOBACTAM FOR INJECTIONPIPERACILLIN & TAZOBACTAM FORPIPERACILLIN AND TAZOBACTAM FOR INJECTIO | $11.0M | 12 | 12.4% |
| 4 | ASTRAL STERITECH PRIVATE LIMITED ASTAZ-P EACH VL CONT.PIPERACILLIN SODIUPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOS | $5.9M | 4 | 6.7% |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED PIPERACILLIN & TAZOBACTAM FOR INJECTIONPIPERACILLIN & TAZOBACTAM FORPIPERACILLIN AND TAZOBACTAM FOR INJECTIO | $4.6M | 8 | 5.2% |
| 6 | MS EUGIA SEZ PRIVATE LIMITED PIPERACILLIN & TAZOBACTAM FOR INJECTIONPIPERACILLIN & TAZOBACTAM FORPIPERACILLIN AND TAZOBACTAM FOR INJECTIO | $4.5M | 4 | 5.1% |
| 7 | UNI MEDICOLABS PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $3.3M | 3 | 3.7% |
| 8 | KILITCH DRUGS (INDIA) LIMITED. PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $1.1M | 1 | 1.2% |
| 9 | SWISS PARENTERALS LIMITED PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $1.0M | 9 | 1.2% |
| 10 | ACULIFE HEALTHCARE PRIVATE LIMITED | $867.2K | 5 | 1.0% |
| 11 | STALLION LABORATORIES PVT LTD PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $755.1K | 1 | 0.9% |
| 12 | VENUS REMEDIES LIMITED PIPERACILLIN AND TAZOBACTAM FOR INJECTION USP 4.5 GMPIPERACILLIN & TAZOBACTAM FOR INJECTION 4.5GPIPERACILLIN & TAZOBACTAM FOR INJECTION | $730.8K | 13 | 0.8% |
| 13 | CIPLA LIMITED | $712.1K | 3 | 0.8% |
| 14 | INJECT CARE PARENTERALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $510.9K | 9 | 0.6% |
| 15 | KILITCH DRUGS INDIA LIMITED PHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GMPHARMACEUTICAL PRODUCTS- PIPETASAPH-4.5GM NOSTAZACIN BATC | $458.7K | 1 | 0.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Piperacillin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Approved | Yes | Yes | 179 | Received FDA warning letter for CGMP deviations; subsequent closeout letter issu |
| Eugia Pharma Specialities Limited | Approved | Yes | Yes | 179 | Received FDA warning letter for CGMP violations; facility classified as 'Officia |
| Eugia Steriles Private Limited | Approved | Yes | Yes | 179 | New injectables facility received first FDA product approval for Lidocaine Hydro |
| APL Healthcare Limited | Approved | Yes | Yes | 179 | Unit IV received WHO approval following inspection in September 2023. |
TransData Nexus reviewed the regulatory standing of 4 leading Piperacillin exporters from India. 4 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 4 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Piperacillin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, which is home to over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy's Laboratories, Aurobindo Pharma, and Divi's Laboratories. This concentration of companies, coupled with advanced research and development infrastructure, positions Hyderabad as a key player in the manufacturing of APIs like piperacillin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to major companies such as Zydus, Intas, Torrent, and Cadila Pharmaceuticals. The region's robust infrastructure, including well-developed ports and transportation networks, facilitates efficient production and export of pharmaceutical products, including piperacillin formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for India's pharmaceutical industry. With 929 pharmaceutical units, Maharashtra is a significant contributor to the country's pharmaceutical output. The region's proximity to major ports and international airports enables seamless export operations, making it a strategic location for companies involved in the production and export of antibiotics like piperacillin.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, housing over 1,000 pharmaceutical units. The region's growth has been bolstered by favorable government policies, including tax incentives and exemptions, which have attracted numerous pharmaceutical companies. Baddi is recognized as Asia's largest pharmaceutical hub, contributing significantly to India's pharmaceutical exports.
5Sourcing Recommendations
- Supplier Diversification: Given that the top five exporters account for 73% of piperacillin shipments, it's advisable to diversify suppliers to mitigate risks associated with over-reliance on a few sources.
- Cluster Specialization: Leverage the strengths of each pharmaceutical cluster. For instance, source APIs from Hyderabad and formulations from the Ahmedabad-Vadodara region to optimize quality and cost.
- Regulatory Compliance: Ensure that selected suppliers comply with international regulatory standards, such as those set by the FDA, EMA, and WHO, to facilitate smooth export processes.
- Logistics Optimization: Utilize the Mumbai-Thane-Raigad region's infrastructure for efficient export logistics, reducing transit times and costs for international shipments.
By strategically selecting suppliers from these specialized clusters and considering the outlined recommendations, companies can enhance their supply chain resilience and efficiency in sourcing piperacillin from India.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Piperacillin exporters from India
Eugia U.S. Manufacturing (a subsidiary of Aurobindo Pharma Limited) — Empower Pharma to acquire Eugia's New Jersey facility
Empower Pharma announced an agreement to purchase the East Windsor, New Jersey manufacturing facility from Eugia U.S. Manufacturing, a wholly owned subsidiary of Aurobindo Pharma. The transaction includes the facility's operations, assets, and workforce. - IMPACT: This divestiture may lead to a strategic realignment of Aurobindo Pharma's manufacturing capabilities, potentially affecting Piperacillin production and export dynamics.
Impact: This divestiture may lead to a strategic realignment of Aurobindo Pharma's manufacturing capabilities, potentially affecting Piperacillin production and export dynamics.
TheraNym Biologics (a wholly owned subsidiary of Aurobindo Pharma Limited) — TheraNym partners with Merck for biologics manufacturing
TheraNym Biologics entered into an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: While this collaboration focuses on biologics, it may influence Aurobindo Pharma's resource allocation, indirectly impacting Piperacillin production and exports.
Impact: While this collaboration focuses on biologics, it may influence Aurobindo Pharma's resource allocation, indirectly impacting Piperacillin production and exports.
Aurobindo Pharma Limited — Aurobindo Pharma acquires Apotex's European businesses
Aurobindo Pharma signed a definitive agreement to acquire Apotex's businesses in Poland, the Czech Republic, the Netherlands, Spain, and Belgium, pending competition clearances from Dutch and Polish authorities. - IMPACT: This acquisition could enhance Aurobindo Pharma's distribution network in Europe, potentially increasing Piperacillin exports to these markets.
Impact: This acquisition could enhance Aurobindo Pharma's distribution network in Europe, potentially increasing Piperacillin exports to these markets.
Common Questions — Piperacillin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which piperacillin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 276 recorded shipments worth $27.9M. STERISCIENCE SPECIALTIES PRIVATE LIMITED (195 shipments) and AUROBINDO PHARMA LIMITED (99 shipments) are also established high-volume exporters.
Q How many piperacillin manufacturers are there in India?
India has 280 active piperacillin exporters with a combined export market of $88.2M across 2,138 shipments to 111 countries. The top 5 suppliers hold 73.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for piperacillin from India?
Average FOB unit price: $8.53 per unit, ranging from $0.00 to $914.44. Average shipment value: $41.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 280 verified Indian exporters of Piperacillin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,138 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 111 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,138 Verified Shipments
280 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists